The Future of Androgenetic Alopecia Treatment (2026 update of existing and new emerging treatments)

Introduction

If you’ve looked into androgenetic alopecia hair loss treatments, you’ve probably come across the same two options again and again: minoxidil, finasteride and PRP.

But research into androgenetic alopecia is moving forward quickly.

A 2026 scientific review published in Frontiers in Pharmacology looked at the newest treatments being developed — including regenerative therapies, advanced drug formulations, and biological approaches designed to repair hair follicles.

In this article, I’ll translate what that research actually means — and what is (and isn’t) worth your attention.

The problem with current treatments

Androgenetic alopecia is a gradual process where:

• Hair follicles shrink (miniaturise)

• Growth cycles shorten

• Hair becomes finer and weaker over time

Current treatments:

• Minoxidil → stimulates growth phase (anagen)

• Finasteride → reduces DHT

They work — but:

• Results vary

• They require long-term use

• They don’t reverse the underlying biology

This is why newer treatments are being explored.

The shift is toward optimism the follicle environment

PRP: still the most established regenerative treatment

Platelet-Rich Plasma (PRP) remains one of the most studied regenerative options.

It works by:

• Delivering growth factors directly to the scalp

• Stimulating dermal papilla cells

• Improving blood supply

Clinical data shows:

• Increased hair density

• Increased hair thickness

• Better results when combined with minoxidil

However, results depend heavily on:

• Technique

• Preparation method

• Treatment protocol

This is where outcomes vary significantly between clinics. For more information about our approach to PRP at Growth Factor Hair Clinic click here

Exosomes and stem cells: promising but early

You may have seen exosome treatments advertised.

These aim to:

• Activate growth pathways (Wnt/β-catenin)

• Stimulate follicle stem cells

• Improve vascular supply

Early studies show improvements in hair density and thickness.

But:

• Treatments are not standardised

• Products vary widely

• There is no regulatory approval yet

👉 In simple terms: promising potential, but safety concerns hence blocked by regulations.

We choose not to offer Exosomes treatments at Growth Factor Hair Clinic currently. This article The Emperor’s New Exosomes explains why.

Peptides and growth factor treatments

These are designed to mimic natural biological signals that control hair growth.

Some studies show:

• Increased hair shaft diameter

• Improved follicle activity

But most data is:

• Small-scale

• Early-stage

These are likely to become adjunct treatments, not stand-alone solutions.

New medications on the horizon

Two developments are particularly interesting:

1. Pyrilutamide

This is a really interesting one with huge potential. instead of trying to reduce DHT generally, Pyrilutamide works instead at the follicle level - addressing over sensitivity of hair follicles to DHT - rather than trying to reduce DHT.

This is the new development we’re most excited about because it has real potential to be a game changer for androgenetic Alopecia.

• A topical anti-androgen

• Blocks DHT at the follicle level

• May avoid systemic side effects

Definitely one to watch. Currently still in trials so not available to use as yet.

2. Extended-release oral minoxidil

• Designed for longer-lasting effect

• May improve consistency of results

Also still in trials.

What actually matters for patients today

Despite all of this innovation, the reality is:

• The core treatments haven’t changed yet

• The best results come from combining therapies

• The quality of treatment delivery matters more than the label

My clinical view

Most people don’t need “the newest treatment.”

They need:

• The right diagnosis

• The right combination

• The right expectations

And just as importantly:

• To avoid treatments that are unlikely to work for them

Final thought

The future of hair loss treatment is clearly moving toward regeneration.

But we are not fully there yet.

For now, the best approach is:

• Use proven treatments

• Enhance them intelligently

• Stay grounded in evidence

  
  

  What actually works right now (2026)

  
  

  Summary:

  
  

  • Minoxidil ✅

  • Finasteride ✅

  • PRP ✅ (selected patients)

  • Exosomes ⚠️ early and safety questions

  • Peptides ⚠️ limited evidence

For more information on Androgenetic Alopecia: https://www.growthfactorhairclinic.co.uk/androgenetic-alopecia

Authored by Dr Gwen Adey BDS MFDS RCS

First published 6/4/26